NO20110582L - Mutasjon av parkingen, preparater, fremgangsmater og anvendelser - Google Patents
Mutasjon av parkingen, preparater, fremgangsmater og anvendelserInfo
- Publication number
- NO20110582L NO20110582L NO20110582A NO20110582A NO20110582L NO 20110582 L NO20110582 L NO 20110582L NO 20110582 A NO20110582 A NO 20110582A NO 20110582 A NO20110582 A NO 20110582A NO 20110582 L NO20110582 L NO 20110582L
- Authority
- NO
- Norway
- Prior art keywords
- gene
- parkin
- exons
- deletion
- amplifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
- C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9814524A FR2786199B1 (fr) | 1998-11-19 | 1998-11-19 | Mutations du gene de la parkine, compositions, methodes et utilisations |
US12423999P | 1999-03-12 | 1999-03-12 | |
FR9910140A FR2797272B1 (fr) | 1999-08-04 | 1999-08-04 | Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations |
PCT/FR1999/002833 WO2000031253A2 (fr) | 1998-11-19 | 1999-11-18 | Mutations du gene de la parkine, compositions, methodes et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20110582L true NO20110582L (no) | 2001-07-18 |
NO333907B1 NO333907B1 (no) | 2013-10-14 |
Family
ID=27253486
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012342A NO330896B1 (no) | 1998-11-19 | 2001-05-11 | Nukleinsyre som koder for en mutert form av h-parkin, polypeptid, antistoff,sammensetning, probe, fremgangsmater, vektor, celle, ikke-humant pattedyr samt anvendelser. |
NO20110582A NO333907B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse. |
NO20110577A NO332174B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse |
NO20110580A NO333906B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse |
NO20110578A NO332173B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012342A NO330896B1 (no) | 1998-11-19 | 2001-05-11 | Nukleinsyre som koder for en mutert form av h-parkin, polypeptid, antistoff,sammensetning, probe, fremgangsmater, vektor, celle, ikke-humant pattedyr samt anvendelser. |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20110577A NO332174B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse |
NO20110580A NO333906B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse |
NO20110578A NO332173B1 (no) | 1998-11-19 | 2011-04-14 | Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse. |
Country Status (15)
Country | Link |
---|---|
US (3) | US8835618B2 (no) |
EP (5) | EP2128257A3 (no) |
JP (1) | JP5424519B2 (no) |
AT (1) | ATE440138T1 (no) |
AU (1) | AU778281B2 (no) |
CA (1) | CA2351567C (no) |
CY (1) | CY1110535T1 (no) |
DE (1) | DE69941300D1 (no) |
DK (1) | DK1131424T3 (no) |
ES (1) | ES2330281T3 (no) |
IL (3) | IL142755A0 (no) |
NO (5) | NO330896B1 (no) |
NZ (1) | NZ512313A (no) |
PT (1) | PT1131424E (no) |
WO (1) | WO2000031253A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1081225A1 (en) * | 1999-08-30 | 2001-03-07 | Biofrontera Pharmaceuticals GmbH | Transgenic animal model for neurodegenerative diseases |
US20040248092A1 (en) * | 2000-05-26 | 2004-12-09 | Vance Jeffrey M | Methods of screening for parkinsons's disease |
FR2845245A1 (fr) * | 2002-10-07 | 2004-04-09 | Aventis Pharma Sa | Modele animal de la maladie de parkinson |
US7790390B2 (en) | 2004-10-27 | 2010-09-07 | Duke University | Methods for identifying an individual at increased risk of developing coronary artery disease |
US7807465B2 (en) | 2004-10-27 | 2010-10-05 | Duke University | Methods for identifying an individual at increased risk of developing coronary artery disease |
CN110295147A (zh) * | 2019-07-22 | 2019-10-01 | 新乡医学院 | 一种食管癌细胞系中功能基因敲除后增殖表型的快速鉴定方法及其应用 |
CA3179402A1 (en) * | 2020-05-21 | 2021-11-25 | Jennifer Johnston | Gene therapy delivery of parkin mutants having increased activity to treat parkinson's disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817478A (en) * | 1993-10-05 | 1998-10-06 | Asahi Glass Company Ltd. | Multicloning vector, expression vector and production of foreign proteins by using the expression vector |
CN1151269C (zh) | 1995-06-06 | 2004-05-26 | 扬·维吉 | 用于诊断性dna检测的方法 |
WO1999040191A1 (fr) * | 1998-02-09 | 1999-08-12 | Boehringer Ingelheim International Gmbh | Adn ou genes contribuant au developpement de la maladie de parkinson |
CA2996759A1 (fr) * | 1998-11-19 | 2000-06-02 | Aventis Pharma S.A. | Mutations du gene de la parkine, compositions, methodes et utilisations |
-
1999
- 1999-11-18 DE DE69941300T patent/DE69941300D1/de not_active Expired - Lifetime
- 1999-11-18 EP EP09167384A patent/EP2128257A3/fr not_active Withdrawn
- 1999-11-18 EP EP10184027A patent/EP2311954A1/fr not_active Withdrawn
- 1999-11-18 CA CA2351567A patent/CA2351567C/fr not_active Expired - Lifetime
- 1999-11-18 EP EP10184008A patent/EP2345722A1/fr not_active Withdrawn
- 1999-11-18 AT AT99956079T patent/ATE440138T1/de active
- 1999-11-18 EP EP10184042A patent/EP2305816A1/fr not_active Withdrawn
- 1999-11-18 AU AU12769/00A patent/AU778281B2/en not_active Ceased
- 1999-11-18 NZ NZ512313A patent/NZ512313A/en not_active IP Right Cessation
- 1999-11-18 ES ES99956079T patent/ES2330281T3/es not_active Expired - Lifetime
- 1999-11-18 EP EP99956079A patent/EP1131424B1/fr not_active Expired - Lifetime
- 1999-11-18 IL IL14275599A patent/IL142755A0/xx unknown
- 1999-11-18 PT PT99956079T patent/PT1131424E/pt unknown
- 1999-11-18 JP JP2000584062A patent/JP5424519B2/ja not_active Expired - Lifetime
- 1999-11-18 WO PCT/FR1999/002833 patent/WO2000031253A2/fr active Application Filing
- 1999-11-18 DK DK99956079T patent/DK1131424T3/da active
-
2001
- 2001-04-23 IL IL142755A patent/IL142755A/en not_active IP Right Cessation
- 2001-05-11 NO NO20012342A patent/NO330896B1/no not_active IP Right Cessation
-
2007
- 2007-11-26 IL IL187652A patent/IL187652A/en not_active IP Right Cessation
-
2009
- 2009-11-11 CY CY20091101178T patent/CY1110535T1/el unknown
-
2011
- 2011-04-14 NO NO20110582A patent/NO333907B1/no not_active IP Right Cessation
- 2011-04-14 NO NO20110577A patent/NO332174B1/no not_active IP Right Cessation
- 2011-04-14 NO NO20110580A patent/NO333906B1/no not_active IP Right Cessation
- 2011-04-14 NO NO20110578A patent/NO332173B1/no not_active IP Right Cessation
- 2011-08-15 US US13/209,495 patent/US8835618B2/en not_active Expired - Fee Related
-
2014
- 2014-08-07 US US14/454,026 patent/US9540693B2/en not_active Expired - Fee Related
-
2016
- 2016-11-04 US US15/343,323 patent/US20170183736A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20110577L (no) | Mutasjon av parkingen, preparater, fremgangsmater og anvendelser | |
Kılınç et al. | Human population dynamics and Yersinia pestis in ancient northeast Asia | |
ATE269416T1 (de) | Verwendung von vereinigten sonden zur genetischen analyse | |
ATE310819T1 (de) | Säugetieren apoptosis inhibitorprotein genfamilie,primers, probes und verfahren zur nachweis | |
Nakano et al. | Variants in pancreatic carboxypeptidase genes CPA2 and CPB1 are not associated with chronic pancreatitis | |
JP2002521065A5 (no) | ||
JP2003517830A5 (no) | ||
AU614489B2 (en) | Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells | |
Owerbach et al. | Inheritance of a parotid secretory protein in mice and its use in determining salivary amylase quantitative variants | |
Broome et al. | Non‐invasive transgenic mouse genotyping using stool analysis | |
Levenson | Mechanisms of copper conservation in organs | |
Van Zutphen | Serum esterase genetics in rabbits. II. Genetic analysis of the prealbumin esterase system, including atropinesterase and cocainesterase polymorphism | |
Karim et al. | Molecular genetic study of a large inbred Pakistani family affected with autosomal recessive congenital ichthyosis through whole exome sequencing | |
ATE373095T1 (de) | Mutierte muskelspezifische enhancer | |
ATE315104T1 (de) | Glaukom diagnose und behandlung | |
WO2002086113A3 (en) | Enzyme and snp marker for disease | |
CN101240325A (zh) | 一种检测遗传基因修复能力的试剂盒 | |
Silverton | CRIME AND THE SCHIZOPHRENIA SPECTRUM: A STUDY OF TWO DANISH COHORTS. | |
Henry | Differentiation of allozyme loci to distinguish between two species of Eisenia | |
EP1446485A4 (en) | DIAGNOSIS PROCEDURE FOR CANCER MARKED BY IDENTIFICATION OF THE DELETION OF THE G-CSF EXONS 3 | |
Friedberg et al. | Calculation and verification of the ages of retroprocessed pseudogenes | |
Zeng et al. | Screening and mutation analysis of phenylalanine hydroxylase deficiency in newborns from Jiangxi province | |
Harris | Mutagenicity of chemicals and drugs | |
Basset et al. | Identification of three Sorex species with microsatellite markers | |
CN117925850A (zh) | 一种与泥蚶血红素浓度相关的snp位点及其在亲本选育中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |